Takeda Pharmaceutical Co Stock Analysis
TAK Stock | USD 13.03 0.04 0.31% |
Takeda Pharmaceutical Co is undervalued with Real Value of 16.27 and Target Price of 19.12. The main objective of Takeda Pharmaceutical stock analysis is to determine its intrinsic value, which is an estimate of what Takeda Pharmaceutical Co is worth, separate from its market price. There are two main types of Takeda Pharmaceutical's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Takeda Pharmaceutical's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Takeda Pharmaceutical's stock to identify patterns and trends that may indicate its future price movements.
The Takeda Pharmaceutical stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Takeda Pharmaceutical is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Takeda Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Takeda Pharmaceutical's ongoing operational relationships across important fundamental and technical indicators.
Takeda |
Takeda Stock Analysis Notes
The company has price-to-book ratio of 0.95. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Takeda Pharmaceutical last dividend was issued on the 28th of September 2023. Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan. Takeda Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 47347 people. To find out more about Takeda Pharmaceutical Co contact Neil Swift at 81 3 3278 2111 or learn more at https://www.takeda.com.Takeda Pharmaceutical Quarterly Total Revenue |
|
Takeda Pharmaceutical Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Takeda Pharmaceutical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Takeda Pharmaceutical Co or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Takeda Pharmaceutical generated a negative expected return over the last 90 days | |
Takeda Pharmaceutical has high likelihood to experience some financial distress in the next 2 years | |
Latest headline from finance.yahoo.com: Down -5.9 percent in 4 Weeks, Heres Why Takeda Pharmaceutical Co. Looks Ripe for a Turnaround |
Takeda Pharmaceutical Upcoming and Recent Events
Earnings reports are used by Takeda Pharmaceutical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Takeda Pharmaceutical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
1st of February 2024 Upcoming Quarterly Report | View | |
9th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
9th of May 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of March 2023 Last Financial Announcement | View |
Takeda Largest EPS Surprises
Earnings surprises can significantly impact Takeda Pharmaceutical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2023-05-22 | 2023-03-31 | 0.0505 | 0.074 | 0.0235 | 46 | ||
2022-10-27 | 2022-09-30 | 0.1757 | 0.1345 | -0.0412 | 23 | ||
2018-10-31 | 2018-09-30 | 0.23 | 0.2736 | 0.0436 | 18 |
Takeda Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Takeda Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Takeda Pharmaceutical Co backward and forwards among themselves. Takeda Pharmaceutical's institutional investor refers to the entity that pools money to purchase Takeda Pharmaceutical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Northern Trust Corp | 2023-12-31 | 1.8 M | Blackrock Inc | 2023-12-31 | 1.8 M | Managed Asset Portfolios, Llc | 2023-12-31 | 1.8 M | Envestnet Asset Management Inc | 2023-12-31 | 1.6 M | Causeway Capital Management Llc | 2023-12-31 | 1.3 M | Van Eck Associates Corporation | 2023-12-31 | 1.3 M | Y.d. More Investments Ltd | 2023-12-31 | 1.3 M | Jane Street Group, Llc | 2023-12-31 | 1.1 M | Old Mission Capital Llc | 2023-12-31 | 1 M | Capital Research Global Investors | 2023-12-31 | 14.3 M | Goldman Sachs Group Inc | 2023-12-31 | 8.6 M |
Takeda Market Capitalization
The company currently falls under 'Large-Cap' category with a total capitalization of 41.23 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Takeda Pharmaceutical's market, we take the total number of its shares issued and multiply it by Takeda Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Takeda Profitablity
Takeda Pharmaceutical's profitability indicators refer to fundamental financial ratios that showcase Takeda Pharmaceutical's ability to generate income relative to its revenue or operating costs. If, let's say, Takeda Pharmaceutical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Takeda Pharmaceutical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Takeda Pharmaceutical's profitability requires more research than a typical breakdown of Takeda Pharmaceutical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 0.04 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.09 %, which entails that for every 100 dollars of revenue, it generated $0.09 of operating income. Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.07 | 0.09 | |
Return On Capital Employed | 0.05 | 0.05 | |
Return On Assets | 0.03 | 0.02 | |
Return On Equity | 0.06 | 0.1 |
Management Efficiency
Takeda Pharmaceutical has Return on Asset of 0.0261 % which means that on every $100 spent on assets, it made $0.0261 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0276 %, implying that it generated $0.0276 on every 100 dollars invested. Takeda Pharmaceutical's management efficiency ratios could be used to measure how well Takeda Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Takeda Pharmaceutical's Return On Tangible Assets are quite stable compared to the past year. Return On Equity is expected to rise to 0.1 this year, although the value of Return On Capital Employed will most likely fall to 0.05. At this time, Takeda Pharmaceutical's Total Current Liabilities is quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 16.9 T this year, although the value of Non Current Liabilities Other will most likely fall to about 383.9 B.Last Reported | Projected for Next Year | ||
Book Value Per Share | 3.7 K | 3.9 K | |
Net Current Asset Value | 0.00 | 0.00 | |
Tangible Asset Value | 0.00 | 0.00 | |
Tangible Book Value Per Share | -2 K | -1.9 K | |
Enterprise Value Over EBITDA | 5.40 | 8.57 | |
Price Book Value Ratio | 0.62 | 0.59 | |
Enterprise Value Multiple | 5.40 | 8.57 | |
Price Fair Value | 0.62 | 0.59 | |
Enterprise Value | 6.5 T | 3.8 T |
The analysis of Takeda Pharmaceutical's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Takeda Pharmaceutical's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Takeda Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Dividend Yield 0.049 | Forward Dividend Yield 0.049 | Forward Dividend Rate 0.64 | Beta 0.543 |
Technical Drivers
As of the 28th of April, Takeda Pharmaceutical has the Risk Adjusted Performance of (0.08), coefficient of variation of (761.11), and Variance of 1.1. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Takeda Pharmaceutical, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to analyze thirteen technical drivers for Takeda Pharmaceutical Co, which can be compared to its competition. Please validate Takeda Pharmaceutical information ratio and potential upside to decide if Takeda Pharmaceutical is priced more or less accurately, providing market reflects its prevalent price of 13.03 per share. Given that Takeda Pharmaceutical has information ratio of (0.22), we advise you to double-check Takeda Pharmaceutical Co's current market performance to make sure the company can sustain itself at a future point.Takeda Pharmaceutical Price Movement Analysis
null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Takeda Pharmaceutical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Takeda Pharmaceutical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Takeda Pharmaceutical Outstanding Bonds
Takeda Pharmaceutical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Takeda Pharmaceutical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Takeda bonds can be classified according to their maturity, which is the date when Takeda Pharmaceutical Co has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
TAKEDA PHARMACEUTICAL LTD Corp BondUS874060AW64 | View | |
TAKEDA PHARMACEUTICAL LTD Corp BondUS874060AX48 | View | |
TAKEDA PHARMACEUTICAL LTD Corp BondUS874060AY21 | View | |
TAKEDA PHARMACEUTICAL LTD Corp BondUS874060AZ95 | View | |
TAKEDA PHARMACEUTICAL LTD Corp BondUS874060BD74 | View |
Takeda Pharmaceutical Predictive Daily Indicators
Takeda Pharmaceutical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Takeda Pharmaceutical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Takeda Pharmaceutical Corporate Filings
25th of April 2024 Other Reports | ViewVerify | |
6K | 19th of April 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
6K | 15th of April 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
F3 | 10th of April 2024 An amendment to the original Schedule 13D filing | ViewVerify |
F3 | 1st of April 2024 An amendment to the original Schedule 13D filing | ViewVerify |
6K | 27th of March 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
6K | 9th of February 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
13A | 6th of February 2024 An amended filing to the original Schedule 13G | ViewVerify |
Takeda Pharmaceutical Forecast Models
Takeda Pharmaceutical's time-series forecasting models are one of many Takeda Pharmaceutical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Takeda Pharmaceutical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Takeda Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Takeda Pharmaceutical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Takeda shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Takeda Pharmaceutical. By using and applying Takeda Stock analysis, traders can create a robust methodology for identifying Takeda entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | 0.11 | 0.10 | |
Operating Profit Margin | 0.14 | 0.21 | |
Net Profit Margin | 0.09 | 0.15 | |
Gross Profit Margin | 0.62 | 0.57 |
Current Takeda Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Takeda analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Takeda analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
19.12 | Strong Buy | 4 | Odds |
Most Takeda analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Takeda stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Takeda Pharmaceutical, talking to its executives and customers, or listening to Takeda conference calls.
Takeda Stock Analysis Indicators
Takeda Pharmaceutical Co stock analysis indicators help investors evaluate how Takeda Pharmaceutical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Takeda Pharmaceutical shares will generate the highest return on investment. By understating and applying Takeda Pharmaceutical stock analysis, traders can identify Takeda Pharmaceutical position entry and exit signals to maximize returns.
Begin Period Cash Flow | 849.7 B | |
Long Term Debt | 4 T | |
Common Stock Shares Outstanding | 1.6 B | |
Total Stockholder Equity | 6.4 T | |
Total Cashflows From Investing Activities | -607.1 B | |
Tax Provision | 58.1 B | |
Quarterly Earnings Growth Y O Y | -0.121 | |
Property Plant And Equipment Net | 1.7 T | |
Cash And Short Term Investments | 553.7 B | |
Cash | 533.5 B | |
Accounts Payable | 649.2 B | |
Net Debt | 3.8 T | |
50 Day M A | 14.0662 | |
Total Current Liabilities | 2.5 T | |
Other Operating Expenses | 3.5 T | |
Non Current Assets Total | 11.6 T | |
Forward Price Earnings | 23.0415 | |
Non Currrent Assets Other | 63.3 B | |
Stock Based Compensation | 60.7 B |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Takeda Pharmaceutical Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Takeda Pharmaceutical information on this page should be used as a complementary analysis to other Takeda Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for Takeda Stock analysis
When running Takeda Pharmaceutical's price analysis, check to measure Takeda Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Takeda Pharmaceutical is operating at the current time. Most of Takeda Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Takeda Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Takeda Pharmaceutical's price. Additionally, you may evaluate how the addition of Takeda Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Takeda Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Takeda Pharmaceutical. If investors know Takeda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Takeda Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.12) | Dividend Share 184 | Earnings Share 0.36 | Revenue Per Share 1.3 K | Quarterly Revenue Growth 0.013 |
The market value of Takeda Pharmaceutical is measured differently than its book value, which is the value of Takeda that is recorded on the company's balance sheet. Investors also form their own opinion of Takeda Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Takeda Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Takeda Pharmaceutical's market value can be influenced by many factors that don't directly affect Takeda Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Takeda Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Takeda Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Takeda Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.